Filter
961
Text search:
European
Medicines
Agency
Featured
Recommendations
100
New Publications
212
Language
Document type
No document type
424
Studies & Reports
226
Guidelines
154
Manuals
56
Strategic & Response Plan
43
Fact sheets
29
Situation Updates
15
Training Material
9
Resource Platforms
3
Brochures
1
Online Courses
1
Countries / Regions
Western and Central Europe
60
Global
46
Ukraine
38
Eastern Europe
25
Africa
22
Sierra Leone
20
Nigeria
18
Liberia
16
Ghana
16
Kenya
16
Nepal
14
Ethiopia
12
Myanmar / Burma
12
Zambia
11
Syria
10
Latin America and the Carribbean
10
India
9
Germany
9
Eastern Europe and Central Asia
9
Guinea
8
Uganda
8
Philippines
8
Rwanda
8
South Africa
8
Bangladesh
8
Moldova
8
Congo, Democratic Republic of
7
West and Central Africa
7
Zimbabwe
6
Thailand
6
Indonesia
6
Burkina Faso
5
South Sudan
5
Tanzania
5
Malawi
5
East and Southern Africa
5
South–East Asia Region
5
Russia
5
Senegal
4
Jordan
4
Namibia
4
Brazil
4
Hungary
4
Botswana
4
Middle East and North Africa
4
Asia
4
Venezuela
4
Poland
4
Georgia
4
Pakistan
3
Cambodia
3
North Macedonia
3
Yemen
3
Albania
3
Romania
3
Jamaica
3
Morocco
2
Afghanistan
2
Lebanon
2
Mozambique
2
Sudan
2
Argentina
2
Eswatini/ Swaziland
2
Serbia
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Bulgaria
2
Iran
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Turkey
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Colombia
1
Ecuador
1
Bolivia
1
Greece
1
Lesotho
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Mongolia
1
Slovakia
1
Kyrgyzstan
1
Australia
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
259
Clinical Guidelines
111
Public Health
57
Women & Child Health
41
Key Resources
28
Pharmacy & Technologies
23
Capacity Building
9
Toolboxes
AMR
90
COVID-19
89
TB
84
HIV
79
Mental Health
66
Pharmacy
53
Conflict
45
Rapid Response
32
Planetary Health
31
Ebola
27
Global Health Education
26
Refugee
23
Disability
18
NCDs
18
Health Financing Toolbox
15
Caregiver
14
NTDs
13
Natural Hazards
9
Zika
7
Specific Hazards
5
Polio
4
Cholera
2
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of
...
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatme
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes
...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019
...
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdd
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Migrants in an irregular situation: access to healthcare in 10 European Union Member States
recommended
This report explores the access to healthcare granted to irregular migrants in 10 EU Member States. It focuses on migrants who are present in an irregular situation, namely those who do not fulfil conditions for entry, stay or residence. Through interviews with a range of different sources including
...
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Harm reduction: evidence, impacts and challenges
-10-
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...